NewGenIvf Share Count Surges Post-Prospectus
Ticker: NIVFW · Form: 6-K · Filed: Jun 20, 2025 · CIK: 1981662
| Field | Detail |
|---|---|
| Company | Newgenivf Group LTD (NIVFW) |
| Form Type | 6-K |
| Filed Date | Jun 20, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-count-increase, corporate-action, prospectus
TL;DR
NewGenIvf's share count exploded from 1.05M to 4.32M since early June. Big changes afoot.
AI Summary
NewGenIvf Group Limited reported on June 20, 2025, that its total issued and outstanding shares have increased to 4,324,565. This includes 4,304,037 Class A ordinary shares and 20,528 Class B ordinary shares. This figure is a significant rise from the 1,050,840 shares disclosed in their prospectus dated June 3, 2025.
Why It Matters
The substantial increase in outstanding shares could indicate new funding rounds, stock issuances, or other corporate actions that may impact the company's valuation and shareholder equity.
Risk Assessment
Risk Level: medium — A rapid increase in share count without immediate context on the reason can signal dilution or significant corporate events that carry inherent risks.
Key Numbers
- 4.32M — Total Shares Outstanding (Represents a significant increase from the previous disclosure.)
- 1.05M — Previous Shares Outstanding (Disclosed in the June 3, 2025 prospectus.)
Key Players & Entities
- NewGenIvf Group Limited (company) — Filer of the report
- 4,324,565 (dollar_amount) — Total issued and outstanding shares as of June 20, 2025
- 4,304,037 (dollar_amount) — Number of Class A ordinary shares
- 20,528 (dollar_amount) — Number of Class B ordinary shares
- 1,050,840 (dollar_amount) — Shares disclosed in prospectus dated June 3, 2025
- June 3, 2025 (date) — Date of most recent prospectus
- June 20, 2025 (date) — Date of the report
FAQ
What is the reason for the significant increase in NewGenIvf Group Limited's outstanding shares?
The filing does not explicitly state the reason for the increase from 1,050,840 shares to 4,324,565 shares, but it notes the change occurred between June 3, 2025, and June 20, 2025.
How many Class A and Class B ordinary shares does NewGenIvf Group Limited have as of June 20, 2025?
As of June 20, 2025, there are 4,304,037 Class A ordinary shares and 20,528 Class B ordinary shares.
When was the previous disclosure of outstanding shares made by NewGenIvf Group Limited?
The company's most recent prospectus, disclosing 1,050,840 shares, was filed on June 3, 2025.
What is the total number of issued and outstanding shares for NewGenIvf Group Limited as of the report date?
The total issued and outstanding shares as of June 20, 2025, is 4,324,565.
Is NewGenIvf Group Limited filing a Form 20-F or Form 40-F for its annual reports?
NewGenIvf Group Limited indicated it files annual reports under Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 20, 2025 regarding NewGenIvf Group Ltd (NIVFW).